Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Magnetic Resonance Imaging | Research

Hemodynamic change in patients with hypertrophic obstructive cardiomyopathy before and after alcohol septal ablation using 4D flow magnetic resonance imaging: a retrospective observational study

Authors: Kenichiro Suwa, Keitaro Akita, Keisuke Iguchi, Takasuke Ushio, Yuichiro Maekawa

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

The hemodynamics in the left ventricle (LV) and the ascending aorta (AAO) before and after alcohol septal ablation (ASA) in patients with hypertrophic obstructive cardiomyopathy (HOCM) is elucidated. Our objective was to evaluate the pattern changes in AAO and intra-LV flow assessed by four-dimensional (4D) flow magnetic resonance imaging (MRI) before and after ASA and to clarify the association between 4D flow MRI-derived hemodynamic characteristics and the peak pressure gradient (PPG) in patients with drug-refractory HOCM.

Methods

In this retrospective observational study, 11 patients with HOCM underwent 4D flow MRI before and a week after ASA. The 4D flow MRI included blood flow visualization and quantification using streamline images. The combined score of vortex and helix in AAO was analyzed. The duration and phase count of the AAO vortex or helix flow and the size of the intra-LV anterior vortex were quantified. The correlation between the changes in hemodynamics and the resting PPG at LV outflow tract was also analyzed. We used the paired t-test for the comparison between before and after ASA and the Pearson’s correlation coefficient for the analysis.

Results

The combined score for the incidence of vortex and/or helix flow in AAO after ASA was significantly lower than that before ASA (1.45 ± 0.52 vs. 1.09 ± 0.30, p = 0.046). The duration (744 ± 291 ms vs. 467 ± 258 ms, p < 0.001) and phase count (14.8 ± 4.4 phases vs. 10.5 ± 5.8 phases, p < 0.001) of the vortex or helix flow in AAO were significantly decreased after ASA. The LV anterior vortex area after ASA was significantly larger than that before ASA (1628 ± 420 mm2 vs. 2974 ± 539 mm2, p = 0.009). The delta phase count of the AAO vortex or helix before and a week after ASA was significantly correlated with delta PPG before and a week after ASA (R = 0.79, p = 0.004) and with delta PPG before and 6 months after ASA (R = 0.83, p = 0.002).

Conclusions

Lower vortex or helix flow in AAO and larger diastolic vortex flow in LV were observed after ASA, which suggests the possibility to detect the changes of aberrant hemodynamics in HOCM.
Appendix
Available only for authorised users
Literature
1.
go back to reference Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruction on clinical outome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295–303.CrossRef Maron MS, Olivotto I, Betocchi S, Casey SA, Lesser JR, Losi MA, et al. Effect of left ventricular outflow tract obstruction on clinical outome in hypertrophic cardiomyopathy. N Engl J Med. 2003;348:295–303.CrossRef
2.
go back to reference Autore C, Bernabò P, Barillà CS, Bruzzi P, Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol. 2005;45:1076–80.CrossRef Autore C, Bernabò P, Barillà CS, Bruzzi P, Spirito P. The prognostic importance of left ventricular outflow obstruction in hypertrophic cardiomyopathy varies in relation to the severity of symptoms. J Am Coll Cardiol. 2005;45:1076–80.CrossRef
3.
go back to reference Elliott PM, Gimeno JR, Tomé MT, Shah J, Ward D, Thaman R, et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J. 2006;27:1933–41.CrossRef Elliott PM, Gimeno JR, Tomé MT, Shah J, Ward D, Thaman R, et al. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy. Eur Heart J. 2006;27:1933–41.CrossRef
4.
go back to reference Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470–6.CrossRef Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46:470–6.CrossRef
5.
go back to reference Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, et al. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008;118:131–9.CrossRef Sorajja P, Valeti U, Nishimura RA, Ommen SR, Rihal CS, Gersh BJ, et al. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2008;118:131–9.CrossRef
6.
go back to reference Veselka J, Jensen MK, Liebregts M, Januska J, Krejci J, Bartel T, et al. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry. Eur Heart J. 2016;37:1517–23.CrossRef Veselka J, Jensen MK, Liebregts M, Januska J, Krejci J, Bartel T, et al. Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry. Eur Heart J. 2016;37:1517–23.CrossRef
7.
go back to reference Maekawa Y, Akita K, Takanashi S. Contemporary septal reduction therapy in drug-refractory hypertrophic obstructive cardiomyopathy. Circ J. 2018;82:1977–84.CrossRef Maekawa Y, Akita K, Takanashi S. Contemporary septal reduction therapy in drug-refractory hypertrophic obstructive cardiomyopathy. Circ J. 2018;82:1977–84.CrossRef
8.
go back to reference Knight CJ. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Heart. 2006;92:1339–44.CrossRef Knight CJ. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Heart. 2006;92:1339–44.CrossRef
9.
go back to reference Barker AJ, Markl M, Bürk J, Lorenz R, Bock J, Bauer S, et al. Bicuspid aortic valve is associated with altered wall shear stress in the ascending aorta. Circ Cardiovasc Imaging. 2012;5:457–66.CrossRef Barker AJ, Markl M, Bürk J, Lorenz R, Bock J, Bauer S, et al. Bicuspid aortic valve is associated with altered wall shear stress in the ascending aorta. Circ Cardiovasc Imaging. 2012;5:457–66.CrossRef
10.
go back to reference von Knobelsdorff-Brenkenhoff F, Karunaharamoorthy A, Trauzeddel RF, Barker AJ, Blaszczyk E, Markl M, et al. Evaluation of aortic blood flow and wall shear stress in aortic stenosis and its association with left ventricular remodeling. Circ Cardiovasc Imaging. 2016;9:e004038.CrossRef von Knobelsdorff-Brenkenhoff F, Karunaharamoorthy A, Trauzeddel RF, Barker AJ, Blaszczyk E, Markl M, et al. Evaluation of aortic blood flow and wall shear stress in aortic stenosis and its association with left ventricular remodeling. Circ Cardiovasc Imaging. 2016;9:e004038.CrossRef
11.
go back to reference Suwa K, Rahman OA, Bollache E, Rose MJ, Rahsepar AA, Carr JC, et al. Effect of aortic valve disease on 3D hemodynamics in patients with aortic dilation and trileaflet aortic valve morphology. J Magn Reson Imaging. 2020;51:481–91.CrossRef Suwa K, Rahman OA, Bollache E, Rose MJ, Rahsepar AA, Carr JC, et al. Effect of aortic valve disease on 3D hemodynamics in patients with aortic dilation and trileaflet aortic valve morphology. J Magn Reson Imaging. 2020;51:481–91.CrossRef
12.
go back to reference Guzzardi DG, Barker AJ, van Ooij P, Malaisrie SC, Puthumana JJ, Belke DD, et al. Valve-related hemodynamics mediate human bicuspid aortopathy: Insights from wall shear stress mapping. J Am Coll Cardiol. 2015;66:892–900.CrossRef Guzzardi DG, Barker AJ, van Ooij P, Malaisrie SC, Puthumana JJ, Belke DD, et al. Valve-related hemodynamics mediate human bicuspid aortopathy: Insights from wall shear stress mapping. J Am Coll Cardiol. 2015;66:892–900.CrossRef
13.
go back to reference Allen BD, Choudhury L, Barker AJ, van Ooij P, Collins JD, Bonow RO, et al. Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging. 2015;16:29–36.CrossRef Allen BD, Choudhury L, Barker AJ, van Ooij P, Collins JD, Bonow RO, et al. Three-dimensional haemodynamics in patients with obstructive and non-obstructive hypertrophic cardiomyopathy assessed by cardiac magnetic resonance. Eur Heart J Cardiovasc Imaging. 2015;16:29–36.CrossRef
14.
go back to reference Garcia J, Barker AJ, Markl M. The role of imaging of flow patterns by 4D flow MRI in aortic stenosis. JACC Cardiovasc Imaging. 2019;12:252–66.CrossRef Garcia J, Barker AJ, Markl M. The role of imaging of flow patterns by 4D flow MRI in aortic stenosis. JACC Cardiovasc Imaging. 2019;12:252–66.CrossRef
15.
go back to reference Authors/Task Force members; Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.CrossRef Authors/Task Force members; Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–79.CrossRef
16.
go back to reference Raut M, Maheshwari A, Swain B. Awareness of ‘systolic anterior motion’ in different conditions. Clin Med Insights Cardiol. 2018;12:1179546817751921.CrossRef Raut M, Maheshwari A, Swain B. Awareness of ‘systolic anterior motion’ in different conditions. Clin Med Insights Cardiol. 2018;12:1179546817751921.CrossRef
17.
go back to reference Suwa K, Saitoh T, Takehara Y, Sano M, Saotome M, Urushida T, et al. Intra-left ventricular flow dynamics in patients with preserved and impaired left ventricular function: analysis with 3D cine phase contrast MRI (4D-Flow). J Magn Reson Imaging. 2016;44:1493–503.CrossRef Suwa K, Saitoh T, Takehara Y, Sano M, Saotome M, Urushida T, et al. Intra-left ventricular flow dynamics in patients with preserved and impaired left ventricular function: analysis with 3D cine phase contrast MRI (4D-Flow). J Magn Reson Imaging. 2016;44:1493–503.CrossRef
18.
go back to reference Akita K, Tsuruta H, Yuasa S, Murata M, Fukuda K, Maekawa Y. Prognostic significance of repeated brain natriuretic peptide measurements after percutaneous transluminal septal myocardial ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy. Open Heart. 2018;5:e000786.CrossRef Akita K, Tsuruta H, Yuasa S, Murata M, Fukuda K, Maekawa Y. Prognostic significance of repeated brain natriuretic peptide measurements after percutaneous transluminal septal myocardial ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy. Open Heart. 2018;5:e000786.CrossRef
19.
go back to reference Sorajja P, Binder J, Nishimura RA, Holmes Jr DR, Rihal CS, Gersh BJ, et al. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv. 2013;81:E58–67.CrossRef Sorajja P, Binder J, Nishimura RA, Holmes Jr DR, Rihal CS, Gersh BJ, et al. Predictors of an optimal clinical outcome with alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Catheter Cardiovasc Interv. 2013;81:E58–67.CrossRef
20.
go back to reference Sorajja P, Ommen SR, Holmes Jr DR, Dearani JA, Rihal CS, Gersh BJ, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126:2374–80.CrossRef Sorajja P, Ommen SR, Holmes Jr DR, Dearani JA, Rihal CS, Gersh BJ, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126:2374–80.CrossRef
21.
go back to reference Sanborn DMY, Sigwart U, Fifer MA. Patient selection for alcohol septal ablation for hypertrophic obstructive cardiomyopathy: clinical and echocardiographic evaluation. Interv Cardiol. 2012;4:349–59.CrossRef Sanborn DMY, Sigwart U, Fifer MA. Patient selection for alcohol septal ablation for hypertrophic obstructive cardiomyopathy: clinical and echocardiographic evaluation. Interv Cardiol. 2012;4:349–59.CrossRef
22.
go back to reference Veselka J, Duchoňová R, Páleníčkova J, Zemánek D, Tišerová M, Linhartová K, et al. Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy—a single-center, prospective, and randomized study. Circ J. 2006;70:1550–2.CrossRef Veselka J, Duchoňová R, Páleníčkova J, Zemánek D, Tišerová M, Linhartová K, et al. Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy—a single-center, prospective, and randomized study. Circ J. 2006;70:1550–2.CrossRef
23.
go back to reference Jain R, Helms A, Day SM, Booher AM. Prevalence of aortic dilation in hypertrophic cardiomyopathy. Am J Cardiovasc Dis. 2013;3:79–84.PubMedPubMedCentral Jain R, Helms A, Day SM, Booher AM. Prevalence of aortic dilation in hypertrophic cardiomyopathy. Am J Cardiovasc Dis. 2013;3:79–84.PubMedPubMedCentral
24.
go back to reference Geske JB, Nordhues BD, Orme NM, Tajik AJ, Spittell PC, Ommen SR. Prevalence and clinical correlates of aortic dilation in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2021;34:279–85.CrossRef Geske JB, Nordhues BD, Orme NM, Tajik AJ, Spittell PC, Ommen SR. Prevalence and clinical correlates of aortic dilation in hypertrophic cardiomyopathy. J Am Soc Echocardiogr. 2021;34:279–85.CrossRef
25.
go back to reference Suwa K, Akita K, Iguchi K, Sugiyama M, Maekawa Y. Improved blood flow after percutaneous transluminal septal myocardial ablation visualized by 4D flow cardiac magnetic resonance in a case of hypertrophic obstructive cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2018;19:1389.CrossRef Suwa K, Akita K, Iguchi K, Sugiyama M, Maekawa Y. Improved blood flow after percutaneous transluminal septal myocardial ablation visualized by 4D flow cardiac magnetic resonance in a case of hypertrophic obstructive cardiomyopathy. Eur Heart J Cardiovasc Imaging. 2018;19:1389.CrossRef
26.
go back to reference Lenz A, Petersen J, Riedel C, Weinrich JM, Kooijman H, Schoennagel BP, et al. 4D flow cardiovascular magnetic resonance for monitoring of aortic valve repair in bicuspid aortic valve disease. J Cardiovasc Magn Reson. 2020;22:29.CrossRef Lenz A, Petersen J, Riedel C, Weinrich JM, Kooijman H, Schoennagel BP, et al. 4D flow cardiovascular magnetic resonance for monitoring of aortic valve repair in bicuspid aortic valve disease. J Cardiovasc Magn Reson. 2020;22:29.CrossRef
27.
go back to reference Bürk J, Blanke P, Stankovic Z, Barker A, Russe M, Geiger J, et al. Evaluation of 3D blood flow patterns and wall shear stress in the normal and dilated thoracic aorta using flow-sensitive 4D CMR. J Cardiovasc Magn Reson. 2012;14:84.CrossRef Bürk J, Blanke P, Stankovic Z, Barker A, Russe M, Geiger J, et al. Evaluation of 3D blood flow patterns and wall shear stress in the normal and dilated thoracic aorta using flow-sensitive 4D CMR. J Cardiovasc Magn Reson. 2012;14:84.CrossRef
28.
go back to reference Bermejo J, Benito Y, Alhama M, Yotti R, Martínez-Legazpi P, del Villar CP, et al. Intraventricular vortex properties in nonischemic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2014;306:H718–29.CrossRef Bermejo J, Benito Y, Alhama M, Yotti R, Martínez-Legazpi P, del Villar CP, et al. Intraventricular vortex properties in nonischemic dilated cardiomyopathy. Am J Physiol Heart Circ Physiol. 2014;306:H718–29.CrossRef
29.
go back to reference Martínez-Legazpi P, Bermejo J, Benito Y, Yotti R, Del Villar CP, González-Mansilla A, et al. Contribution of the diastolic vortex ring to left ventricular filling. J Am Coll Cardiol. 2014;64:1711–21.CrossRef Martínez-Legazpi P, Bermejo J, Benito Y, Yotti R, Del Villar CP, González-Mansilla A, et al. Contribution of the diastolic vortex ring to left ventricular filling. J Am Coll Cardiol. 2014;64:1711–21.CrossRef
30.
go back to reference Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation. 2011;124:40–7.CrossRef Maron MS, Olivotto I, Harrigan C, Appelbaum E, Gibson CM, Lesser JR, et al. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy. Circulation. 2011;124:40–7.CrossRef
31.
go back to reference Cao Y, Sun X-Y, Zhong M, Li L, Zhang M, Lin M-J, et al. Evaluation of hemodynamics in patients with hypertrophic cardiomyopathy by vector flow mapping: comparison with healthy subjects. Exp Ther Med. 2019;17:4379–88.PubMedPubMedCentral Cao Y, Sun X-Y, Zhong M, Li L, Zhang M, Lin M-J, et al. Evaluation of hemodynamics in patients with hypertrophic cardiomyopathy by vector flow mapping: comparison with healthy subjects. Exp Ther Med. 2019;17:4379–88.PubMedPubMedCentral
32.
go back to reference Suwa K, Saitoh T, Takehara Y, Sano M, Saotome M, Urushida T, et al. Intra-left ventricular flow dynamics in patients with preserved and impaired left ventricular function: analysis with 3D cine phase contrast MRI (4D-Flow). J Magn Reson Imaging. 2016;44:1493–503.CrossRef Suwa K, Saitoh T, Takehara Y, Sano M, Saotome M, Urushida T, et al. Intra-left ventricular flow dynamics in patients with preserved and impaired left ventricular function: analysis with 3D cine phase contrast MRI (4D-Flow). J Magn Reson Imaging. 2016;44:1493–503.CrossRef
Metadata
Title
Hemodynamic change in patients with hypertrophic obstructive cardiomyopathy before and after alcohol septal ablation using 4D flow magnetic resonance imaging: a retrospective observational study
Authors
Kenichiro Suwa
Keitaro Akita
Keisuke Iguchi
Takasuke Ushio
Yuichiro Maekawa
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-02003-8

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue